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Introduction: Although the clinical application of procalcitonin (PCT) as an infection marker in patients with
impaired renal function (estimated glomerular filtration rate (eGFR) <60 ml/min/1.73 m2) has been increasing
recently, it is unclear whether PCT is more accurate than C-reactive protein (CRP). We investigated the clinical value
of CRP and PCT based on renal function.
Methods: From November 2008 to July 2011, a total of 493 patients who simultaneously underwent CRP and PCT
tests were enrolled. The area under the receiver operating characteristic (ROC) curve and characteristics of both
markers were analyzed according to infection severity and renal function.
Results: In patients with impaired renal function, the area under the ROC curve was 0.876 for CRP and 0.876 for
PCT. In patients with infection, CRP levels differed depending on whether the infection was localized, septic, or
severely septic, whereas PCT levels were higher in patients with severe sepsis or septic shock. In patients without
infection, CRP did not correlate with eGFR, while PCT was negatively correlated with eGFR.
Conclusion: This study demonstrates that CRP is accurate for predicting infection in patients with impaired renal
function. The study suggests that in spite of its higher cost, PCT is not superior to CRP as an infection marker in
terms of diagnostic value.Introduction
Severe infection and sepsis with accompanying dysfunction
or failure of multiple organs are major causes of morbidity
and mortality in patients with chronic kidney disease (CKD)
[1,2]. These patients are particularly susceptible to infection
because of functional deterioration of many components of
the immune system [3]. However, it is difficult to differenti-
ate between infectious causes and non-infectious causes of
systemic inflammatory responses because of chronic eleva-
tion of inflammatory markers and nonspecific clinical symp-
toms that are common among patients with CKD [4,5]. In
particular, the specificity of C-reactive protein (CRP) has
been of concern because CRP has been found to be* Correspondence: hyeryoun.jang@samsung.com
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such as atherosclerosis and CKD [5,6].
Recently, procalcitonin (PCT) has become widely used
for differentiating between infectious and non-infectious
disease. Some studies have found that PCT is a more
accurate marker for predicting infection than CRP in
patients with impaired renal function as well as in those
with normal renal function [7-9]. However, the diagnos-
tic value or the best cutoff value of PCT in patients with
impaired renal function or renal replacement therapy
(RRT) remains unknown because the elimination route
of PCT has not been described yet. Additionally, previ-
ous studies evaluating PCT in patients with impaired
renal function included either an unrepresentative study
sample or a very small sample size. Although a recent
meta-analysis study reported that both CRP and PCT
have acceptable specificity in diagnosing infection in
patients with impaired renal function, that meta-analysis
included studies with high heterogeneity in the studyis an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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relative advantages of PCT compared to CRP, especially
regarding diagnostic accuracy even with its higher cost
[10,11]. The aim of this study is to evaluate the clinical
relevance of PCT compared to CRP as an infection
marker based on difference in renal function.
Materials and methods
Study population
We performed a cross-sectional study to evaluate the
diagnostic value of PCT compared to CRP in regard to
renal function after obtaining approval from the Institu-
tional Review Board (IRB) at Samsung Medical Center in
compliance with the Declaration of Helsinki (IRB approval
number: 2013-06-020). As we collected data retrospect-
ively, patient consent was not applicable. Study partici-
pants were selected from the patient population at
Samsung Medical Center, a 2,000-bed tertiary referral cen-
ter in Seoul, Korea. Eligible participants were adults (≥18
years old) with suspected infection who underwent CRP
and PCT tests simultaneously (within a 6-hour period) be-
tween 1 November 2008 and 31 July 2011. Patients were
enrolled regardless of the hospitalization setting, such as
ward, intensive care unit, or emergency room, to include
patients with variable disease severity.
The total number of patients who received CRP and PCT
tests within a 6-hour period upon admission during the
study period was 25,075. We recruited 23,819 of these eli-
gible patients and then randomly selected 100 patients from
each class of renal function based on estimated glomerular
filtration rate (eGFR) to enroll patients evenly according to
renal function (class 1: eGFR ≥90 mL/min/1.73 m2; class 2:
eGFR 60 to 90 mL/min/1.73 m2; class 3: eGFR 30 to
60 mL/min/1.73 m2, class 4: eGFR 15 to 30 mL/min/1.73
m2; class 5: eGFR ≤15 mL/min/1.73 m2 without RRT; class
6: eGFR ≤15 mL/min/1.73 m2 with hemodialysis (HD); or
class 7: eGFR ≤15 mL/min/1.73 m2 with peritoneal dialysis
(PD)). After excluding patients with an unclear clinical
course of infection, a total of 493 patients were ultimately
enrolled in this study.
The randomly selected patients were divided into two
groups based on their infection status as determined by
a review of their medical records. Patients were defined
as having an infection when a clinically definable source
of infection was present, as confirmed by microbiology
tests and/or positive blood cultures. In cases of sus-
pected PD peritonitis, a diagnosis was made if the peri-
tosol white blood cell count was greater than 100 cells/
mm3 and the percentage of neutrophils was greater than
50%, even if no microbe was identified [12]. Cases with
clinical ambiguities or obscurities that made it difficult
to classify infection status were excluded. Thus, cases
with no microbiologically-confirmed culture results to
accompany a clinical diagnosis of infection wereexcluded. Likewise, cases with microbiologically-confirmed
culture results but no clinical diagnosis of infection were
also excluded. Additionally, cases without a conclusive clin-
ical diagnosis of systemic inflammatory response or organ
failure were excluded from both groups.
Important clinical and laboratory variables, such as
age, sex, preexisting underlying disease, clinical diagnosis,
severity of infectious condition, microbiology of culture
from infection source, hematologic data, and chemistry
data, were collected when CRP and PCT tests were con-
ducted. The American College of Chest Physicians/Society
of Critical Care Medicine Consensus Conference defin-
ition of sepsis stage was used to classify the severity of
infection as sepsis, severe sepsis, or septic shock [13].
The primary outcome was a comparison between the
reliability of CRP and PCT as diagnostic markers of infec-
tion in patients with impaired renal function. The second-
ary outcomes included the best cutoff value of CRP and
PCT levels in patients with impaired renal function, the
association between CRP and PCT levels and infection
severity in patients with impaired renal function, and the
association between CRP and PCT levels and renal func-
tion in the absence of infection.Measurements
Renal function was assessed based on eGFR levels using
the modification of diet in renal disease (MDRD) equa-
tion. Serum CRP concentrations were measured with an
immunoturbidimetric assay (CRPL3, Roche Diagnostics,
Indianapolis, IN, USA) and the lower reference limit was
0.3 mg/dL. Serum PCT concentrations were measured
with an enzyme-linked fluorescent assay (Brahms Diag-
nostica GmbH, Berlin, Germany) and the lower reference
limit was 0.05 ng/mL.Statistical analyses
For statistical analyses, SPSS PAWS version 20.0 (SPSS
Inc., Chicago, IL, USA) was used. For continuous vari-
ables, data are shown as the median and IQR if the data
were not normally distributed. Categorical data are shown
as the number and percentage. Continuous variables were
analyzed using the Mann-Whitney U-test. The Kruskal-
Wallis test and Tukey test using ranks for post-hoc com-
parison were used for multiple comparisons. Categorical
data were analyzed using the chi-square test. To compare
the predictive ability of CRP and PCT for infection, re-
ceiver operating characteristic (ROC) curves and the areas
under the respective curve (AUC) were calculated. AUCs
were compared using the nonparametric approach of
DeLong et al. for two correlated AUCs [14]. Spearman
correlation analysis was used for nonparametric data.
P-values less than 0.05 were considered statistically
significant.
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Among the 700 patients assessed, 207 patients were ex-
cluded because of clinical ambiguities about their infec-
tion status, as described in Materials and methods. A
total of 493 patients were finally analyzed. Patients were
divided into two groups based on renal function (group
I: eGFR ≥60 mL/min/1.73 m2; group II: eGFR <60 mL/
min/1.73 m2). In group I, 73 patients (48%) had an infec-
tion and 78 patients (52%) did not have an infection,
and in group II, 186 patients (46%) had an infection and
156 patients (54%) did not have an infection.
Baseline characteristics are summarized in Table 1.
There were no significant differences in age, sex, or
major comorbidities (such as diabetes mellitus (DM) or
hypertension) and renal function based on infection
status (Table 1). Disease categories are shown in Table 2.
The most common infectious disease in the sample
population was urinary tract infection (26.6%), followed
by intra-abdominal infection (17.0%) (Table 2). The most
common non-infectious disease was cardiovascular
disease (26.1%) (Table 2).
The median values of CRP and PCTare shown in Table 3.
The median values of CRP and PCT were significantly
higher in patients with infectious diseases (CRP: P <0.001;
PCT: P <0.001). Sub-analyses of CRP and PCT based on
renal function showed that both markers were significantly
elevated in patients with infection (Table 3).
The diagnostic value of CRP and PCT for predicting
infection was compared using the ROC curve. The AUC
for the diagnosis of infection versus non-infection was
0.819 (95% CI 0.782, 0.856) for CRP and 0.831 (95% CI
0.795, 0.866) for PCT (Figure 1a). For group I, the AUC
was 0.684 (95% CI 0.587, 0.782) for CRP and 0.766 (95%
CI 0.681, 0.851) for PCT (Figure 1b). For group II, the
AUC was 0.876 (95% CI 0.839, 0.912) for CRP and 0.876
(95% CI 0.839, 0.912) for PCT (Figure 1c). There were
no differences between the AUCs of CRP and PCT in
the two groups (total: P = 0.59 for all patients;
P = 0.12 for group I; P = 0.9 for group II). When the
AUC of CRP and PCT was analyzed further in patientsTable 1 Baseline characteristics
Total Group
Infection- Infection+ P Infecti
Number 234 259 - 78
Age, yr 61 (24) 62 (20) 0.84 52 (22
Female, % 90 (38.5) 115 (44.4) 0.20 30 (38
DM, % 68 (29.1) 85 (32.8) 0.38 7 (9.0)
HTN, % 104 (44.4) 117 (45.2) 0.9 15 (19
eGFR, mL/min/1.73 m2 29.9 (68.8) 22.2 (63.0) 0.13 104.6 (
Categorical data were analyzed using the chi-square test and continuous variable
(IQR) or number (percentage). Group I: eGFR ≥60 mL/min/1.73 m2, Group II: eGFR
estimated glomerular filtration rate.with systemic inflammatory response syndrome (SIRS)
(excluding patients without SIRS from both groups),
CRP still showed no inferiority to PCT in differentiating
infection. In patients with SIRS, the AUC of CRP was
0.804 (95% CI 0.759, 0.850) and that of PCT was 0.802
(95% CI 0.757, 0.847). In SIRS patients with normal
renal function, the AUC of CRP was 0.629 (95% CI
0.532, 0.725) and that of PCT was 0.694 (95% CI 0.603,
0.785). In SIRS patients with impaired renal function,
the AUC of CRP was 0.890 (95% CI 0.849, 0.931) and
that of PCT was 0.858 (95% CI 0.811, 0.906). CRP was
not inferior to PCT in patients with SIRS.
Additionally, to evaluate whether the diagnostic accur-
acy could be increased using CRP and PCT together, the
AUC of both CRP and PCT together was compared with
the AUC of CRP alone. The AUC of CRP and PCT mea-
surements together was significantly higher than the AUC
of CRP alone (AUC of both CRP and PCT versus AUC of
CRP alone: 0.858 versus 0.819 in all patients, P <0.001;
0.758 versus 0.684 for group I, P = 0.01; 0.899 versus 876
for group II, P = 0.01).
The best cutoff value for diagnosing infection in patients
with impaired renal function (group II) was 3.08 mg/dL
for CRP and 1.1 ng/mL for PCT. In patients with normal
renal function, the best cutoff value was 2.49 mg/dL for
CRP and 0.08 ng/mL for PCT.
The association between CRP and PCT levels and the
severity of infection in patients with impaired renal
function (group II) was also analyzed. Group II patients
with infectious diseases were categorized depending on
the severity of their infections defined as no SIRS, sep-
sis, severe sepsis, or septic shock. Both CRP and PCT
showed significant correlation with infection severity
using Spearman correlation (CRP: P <0.001, r = 0.378;
PCT: P <0.001, r = 0.414). The Kruskal-Wallis test was
also performed to analyze the differences in CRP and
PCT among four subgroups. There were differences in
CRP and PCT among four subgroups (P <0.001 for both
CRP and PCT) (Figure 2). However, the Tukey test
using ranks for post-hoc comparison showed noI Group II
on- Infection+ P Infection- Infection+ P
73 - 156 186 -
) 51 (32) 0.9 69 (24) 66 (18) 0.49
.5) 33 (45.2) 0.83 60 (38.5) 82 (44.1) 0.64
16 (21.9) 0.08 61 (39.1) 69 (37.1) 0.9
.2) 19 (26.0) 0.67 89 (57.1) 98 (52.7) 0.89
59.6) 100.2 (38.1) 0.9 14.4 (20.3) 14.4 (25.3) 0.78
s were analyzed using the Mann-Whitney U-test. Data represent median
<60 mL/min/1.73 m2. DM, diabetes mellitus; HTN, hypertension; eGFR,
Table 2 Disease categories
Disease category Number (%)
Disease categories in patients with infection
Urinary tract infection 69 (26.6)
Intra-abdominal infection 44 (17.0)
Pneumonia 39 (15.1)
Peritonitis 29 (11.2)
Bacteremia with unknown focus 27 (10.4)
Skin and soft tissue infection 26 (10.0)
Vascular infection 13 (5.0)
Catheter related infection 8 (3.1)
Others 4 (1.5)
Total 259 (100)
Disease categories in patients without infection
Cardiovascular disease (atrial fibrillation, myocardial
infarction, heart failure)
61 (26.1)
Renal disease (rhabdomyolysis, thrombotic
thrombocytopenic purpura-hemolytic uremic syndrome)
35 (15.0)
Gastroenterohepatic disease (gastrointestinal bleeding,
toxic hepatitis)
34 (14.5)
Hemato-oncologic disease (lymphoma B symptom,
sarcoidosis)
30 (12.8)
Respiratory disease (chronic obstructive pulmonary
disease, interstitial lung disease)
19 (8.1)
Rheumatologic disease (gout, adult onset Still's disease) 15 (6.4)
Neuropsychiatric disease (cerebral infarction, intracranial
hemorrhage)
13 (5.6)
Endocrinological disease (adrenal insufficiency,
hypoglycemia, diabetic ketoacidosis)
8 (3.4)
Musculoskeletal disease (fractures) 4 (1.7)
Others (drug fever, pain shock) 15 (6.4)
Total 234 (100)
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septic shock (P = 0.549) (Figure 2a). In PCT, the Tukey test
using ranks for post-hoc comparison showed no significant
differences between absence of SIRS and sepsis (P = 0.851)
(Figure 2b).
The correlation between CRP, PCT, and renal function
was analyzed in patients without infection. Patients re-
ceiving renal replacement therapy were excluded in this
analysis. CRP was not correlated with eGFR (P =0.70),
whereas PCT was inversely correlated with eGFR (r =
? 0.247, P = 0.01) (Figure 3).Discussion
This study demonstrated that PCT is not superior to CRP
for diagnostic accuracy, nor is it more reliably associated
with infection severity considering renal function. CRP had
diagnostic accuracy similar to PCT in patients withimpaired renal function as well as in those with normal
renal function. In patients with infection, CRP levels were
higher in cases with less severe infection, which was a sig-
nificantly different result than the levels observed among
patients without SIRS, with sepsis, and with severe sepsis.
PCT increased with more severe infection and there were
no significant differences in PCT levels between patients
with and without SIRS. Among patients without infection,
CRP was not correlated with eGFR, while PCT was in-
versely correlated with eGFR.
A recent meta-analysis found that PCT was not superior
to CRP in patients with impaired renal function [10]. In
that study, hierarchical summary ROC curves had an
AUC of 0.88 (95% CI 0.83, 0.92) for CRP and 0.89 (95% CI
0.86, 0.92) for PCT, which were similar to our results
(AUC: 0.876, 95% CI 0.839, 0.912 for CRP; AUC: 0.876,
95% CI 0.839, 0.912 for PCT). Also in a recent study
including a relatively smaller homogenous population of
CKD patients, AUC was 0.860 (95% CI 0.712, 1.000) for
CRP and 0.911 (95% CI 0.773, 1.000) for PCT. There was
also no significant difference in AUC (P = 0.53, z-statistic =
0.62, 95% CI 0.110, 0.211) [15].
In addition to the finding that PCT is not superior to
CRP, it is also more costly: PCT testing is eight times more
expensive than CRP testing in Korea, and two to four
times more expensive in the US and Europe. Among pa-
tients with normal renal function, our data showed higher
sensitivity and specificity of PCT compared to CRP, which
is consistent with the findings of previous studies [8,9]. Al-
though the kinetics of PCT, including elimination route
and mechanism, have not been fully elucidated, it is pos-
sible that impaired renal function or dialysis may influence
PCT because of its low molecular weight (13 kDa) [16].
Previous studies that evaluated the influence of renal func-
tion or dialysis on PCT yielded inconsistent results
[7,17-22]. Our study demonstrated a weakly significant
correlation between PCT and eGFR in non-infected pa-
tients. This result implies that PCT may be also influenced
by renal function. Furthermore, PCT was not distinctively
elevated in patients with less severe infections, and the
basal level of PCT increased in patients with impaired
renal function [7,8,17-19,22]; thus, a higher cutoff value
for PCT was suggested for use in patients with impaired
renal function [7,10,18]. Similarly, in our study, the best
cutoff values of PCT for diagnosing infection were 1.1 ng/
mL for patients with impaired renal function and 0.08 ng/
mL for patients with normal renal function.
Previous studies that investigated the association between
infection severity and CRP or PCT did not specifically
explore these relationships in patients with impaired
renal function exclusively [8,23,24]. Still, those studies also
found that CRP levels were higher in patients with mild
organ dysfunction and sepsis, but CRP levels did not
increase significantly with progression toward more severe
Table 3 C-reactive protein (CRP) and procalcitonin (PCT) levels by renal function and infection status
CRP, mg/dL PCT, ng/mL
Infection- Infection+ P Infection- Infection+ P
Total 1.12 (3.63) 10.62 (17.94) <0.001 0.15 (0.42) 2.86 (22.73) <0.001
Group I (eGFR ≥60) 2.38 (8.46) 8.42 (10.82) <0.001 0.05 (0.13) 0.45 (4.21) <0.001
Group II (eGFR <60) 0.83 (2.48) 12.08 (20.02) <0.001 0.25 (0.53) 4.76 (32.37) <0.001
eGFR ≥90 2.38 (5.36) 6.09 (10.36) 0.001 0.05 (0.10) 0.21 (1.98) <0.001
60≤ eGFR <90 2.55 (11.45) 11.06 (16.52) 0.03 0.07 (0.20) 1.28 (20.37) <0.001
30≤ eGFR <60 0.96 (2.37) 12.19 (16.46) <0.001 0.09 (0.22) 2.88 (19.80) <0.001
15≤ eGFR <30 0.75 (2.28) 19.86 (21.69) <0.001 0.17 (0.42) 23.22 (77.22) <0.001
eGFR <15
Without RRT 0.62 (2.65) 18.82 (16.54) <0.001 0.25 (0.53) 14.44 (65.76) <0.001
HD 1.89 (3.53) 10.19 (22.12) <0.001 0.55 (0.80) 7.37 (36.34) <0.001
PD 0.40 (1.33) 3.30 (9.78) <0.001 0.40 (0.45) 1.31 (10.74) 0.001
Statistics were analyzed by the Mann ? Whitney U-test. Data represent median (IQR). Group I: eGFR ≥60 mL/min/1.73 m2, Group II: eGFR <60 mL/min/1.73 m2. eGFR,
estimated glomerular filtration rate; RRT, renal replacement therapy; HD, hemodialysis; PD, peritoneal dialysis.
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modestly higher in cases of local infection and cases of in-
fection without multiple organ failure [25]. Similarly, in our
study, CRP levels were significantly different between im-
paired renal function cases without SIRS, with sepsis, and
with severe sepsis. However, there was no significant dif-
ference between CRP levels in cases of severe sepsis and
septic shock. In contrast with CRP results, PCT levels in-
creased in patients with more severe organ dysfunction, se-
vere sepsis, or septic shock. These differences are possibly
due to different sources of CRP and PCT during the in-
flammatory process. CRP is produced only by de novo
hepatic synthesis [6]. Therefore, CRP levels might not be
increased further in patients with hepatic dysfunction, even
under conditions of severe infection, such as septic shock
or severe sepsis. Leukocytes are thought to be the source of
PCT during sepsis, although there is still controversy re-
garding the origins of PCT [26]. During less severe infec-
tion, no SIRS, or sepsis, we observed a subtle increase in
PCT levels, probably due to less specific stimuli to the leu-
kocytes. These different responses, depending on the sever-
ity of infection, suggest that CRP would be a more valuable
infection marker because CRP increases gradually, even in
less severe infection, allowing for differential diagnosis of
SIRS or no SIRS.
Interestingly, our study showed the best accuracy of
CRP and PCT in patients with renal impairment. We
compared the proportion of patients with septic shock
with other subgroups (no SIRS, sepsis, and severe
sepsis) using the chi-square test. The proportion of
septic shock was greater in patients with renal im-
pairment than those with normal renal function (the
proportion of septic shock: 30% in renal impairment,
11% in normal renal function, P = 0.001). However,there was no difference in the overall severity of in-
fection between renal impairment and normal renal
function groups when analyzed by the Wilcoxon rank
sum test (P = 0.133). Although the best accuracy of CRP
and PCT in patients with renal impairment might be af-
fected by the partial proportional difference of infection
severity, we believe that this point did not substantially
compromise the aim of this study to compare CRP and
PCT as an infection marker.
This study has several limitations. First, there may
have been some selection bias because of the retro-
spective design. Because there are no gold standard
criteria for diagnosing infection, there might be some
misclassifications of infection status in this study.
However, the definition of infection has an inevitable
methodological limitation in all similar studies. In
order to overcome this limitation, all ambiguous cases
were excluded from our study. Second, unexpected
factors that could affect CRP and PCT levels were
not concurrently analyzed in this study. However,
cardiovascular disorder, a common factor known to
increase CRP and PCT, was thoroughly analyzed
alongside renal function, and no significant associ-
ation was found between cardiovascular disease and
eGFR (P = 0.64). Third, our study sample was not
large. Nonetheless, we enrolled a comparable number
of patients across each stage of renal function, includ-
ing dialysis patients. Furthermore, to our knowledge,
this study included the largest study population
among single-center studies evaluating the diagnostic
value of PCT in patients with impaired renal function,
although the patient population of our study might
be heterogeneous because of various hospitalization
settings including wards, intensive care units, or
Figure 1 Receiver operating characteristic curves of C-reactive
protein (CRP) and procalcitonin (PCT) for predicting infection.
CRP is shown as solid lines, PCT as broken lines. (a) Receiver
operating characteristic (ROC) curves for predicting infection in all
patients. CRP: area under the curve (AUC) 0.819 (95% CI 0.782,
0.856), best cutoff value 3.08 mg/dL; sensitivity 81%, specificity
71%; positive predictive value (PPV) 0.75, negative predictive value
(NPV) 0.77. PCT: AUC, and best cutoff value 0.831 (95% CI 0.795,
0.866) and 1.1 ng/mL, respectively; sensitivity and specificity 64%
and 90%, respectively; PPV and NPV 0.88 and 0.69, respectively. (b)
ROC curves for prediction of infection in patients with normal renal
function (group I). CRP: AUC, and best cutoff value 0.684 (95% CI
0.587, 0.782) and 2.49 mg/dL, respectively; sensitivity and specificity
82% and 51%, respectively; PPV and NPV 0.61 and 0.75, respectively.
PCT: AUC, and best cutoff value 0.766 (95% CI 0.681, 0.851) and 0.08
ng/mL, respectively; sensitivity and specificity 82% and 60%,
respectively; PPV and NPV 0.66 and 0.78, respectively. (c) ROC
curves for prediction of infection in patients with impaired renal
function. CRP: AUC, and best cutoff value 0.876 (95% CI 0.839, 0.912)
and 3.08 mg/dL, respectively; sensitivity and specificity 82% and
79%, respectively; PPV and NPV 0.83 and 0.79, respectively. PCT:
AUC, and best cutoff value 0.876 (95% CI 0.839, 0.912) and 1.1 ng/
mL, respectively; sensitivity and specificity 73% and 89%,
respectively; PPV and NPV 0.89 and 0.74, respectively.
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the measurement techniques and diagnostic criteria for
infection used in our study were consistent across all
participants.
Conclusions
In conclusion, this study suggests that in spite of its
higher cost, PCT is not superior to CRP as an infection
marker in terms of diagnostic value. The sensitivity and
specificity of PCT and CRP were comparable in our ana-
lyses; however, PCT levels had an inverse relationship
with eGFR in patients with renal insufficiency but no
infection. Finally, considering that PCT levels were not
significantly different between patients without SIRS and
patients with sepsis, CRP would be a more valuable
marker of infection in those patients.
Key messages
 Both CRP and PCT are useful to distinguish
infectious conditions from non-infectious
conditions, not only in patients with normal renal
function, but also in patients with impaired renal
function.
 Although the accuracy of CRP and PCT as infection
markers was comparable in patients with impaired
renal function, there was an inverse relationship
between PCT and eGFR in patients without
infection.
 PCT is not superior to CRP as an infection marker
in terms of diagnostic value in patients with
impaired renal function despite its higher cost.
Figure 2 (See legend on next page.)
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Figure 2 The association between C-reactive protein (CRP) and procalcitonin (PCT) levels and the severity of infection in patients with
impaired renal function. The differences in CRP and PCT among four subgroups were analyzed using the Kruskal-Wallis test. (a) CRP increased
depending on the infection severity (P <0.001). However, there was no difference in CRP between severe sepsis and septic shock (P = 0.549). The
median (IQR) CRP in each subgroup was as follows: 3.74 (7.27) when there was no systemic inflammatory response syndrome (SIRS), 10.41 (18.82)
in sepsis, 18.59 (15.43) in severe sepsis, and 19.26 (21.94) in septic shock. (b) PCT increased depending on the infection severity (P <0.001).
However, PCT was not significantly higher in patients with sepsis than in those without SIRS (P = 0.851). The median (IQR) PCT in each subgroup
was as follows: 1.52 (10.78) in the absence of SIRS, 2.22 (5.51) in sepsis, 7.96 (34.97) in severe sepsis, and 25.41 (85.11) in septic shock.
Figure 3 Association between C-reactive protein (CRP) and procalcitonin (PCT) levels and estimated glomerular filtration rate (eGFR) in
patients with impaired renal function. Spearman correlation analysis was used to obtain r- and P-values. (a) CRP was not correlated with eGFR
(r =0.037, P = 0.70). (b) PCT was significantly correlated with eGFR (r = ? 0.247, P = 0.01).
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